Franklin, Tenn.-based Acadia Healthcare reported a fourth-quarter net loss attributable to Acadia of $13.02 per diluted share after recording a $996.2 million non-cash goodwill impairment charge, the company said in its fourth-quarter and full-year 2025 results.
Here are five things to know:
- Revenue totaled $821.5 million, a 6.1% increase compared with the fourth quarter of 2024. Same facility revenue increased 4.4%, including a 3.1% increase in patient days and a 1.3% increase in revenue per patient day.
- Acute inpatient psychiatric facility revenue was $451 million in the fourth quarter and saw a 10% increase over the prior year’s fourth quarter, with inpatient volumes up 6%.
- Adjusted net income attributable to Acadia totaled $6.1 million, or $0.07 per diluted share, compared with $59.2, or $0.64 per diluted share in the prior-year period. Adjusted EBITDA was $99.8 million, compared with $153.1 million in the prior-year period, and included a $52.7 million adjustment to professional and general liability reserves.
- For full-year 2025, revenue totaled $3.3 billion, a 5% increase compared to the prior year. Net loss attributed to Acadia totaled $12.16 per diluted share, compared with net income of $2.78 per diluted share during the prior year. Adjusted EBITDA was $608.9 million, compared with $709 million in the previous year.
- The company added 181 newly licensed beds during the fourth quarter and 1,089 licensed beds during the year.
- Acadia issued full-year 2026 guidance that includes revenue of $3.37 billion to $3.45 billion and adjusted EBITDA of $575 million to $610 million.
At the Becker's Fall Behavioral Health Summit, taking place November 4–5 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.
